COMPANY

Cognos Therapeutics

HQ: Los Angeles, CA source · cognosthx.com ↗

Keywords: oncology neurology drug delivery

Location: Los Angeles, CA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $250K in debt securities (Form D filed Jul 2, 2026). SEC Form D 0001651490-26-000003 (Jul 2, 2026)
Evidence (1 event)
- Jul 2, 2026 · SEC Form D 0001651490-26-000003
  Name of Issuer: Cognos Therapeutics Inc; CIK: 1651490; Address: Inglewood, CA; Submission type: D; Filing date: 2026-07-02; Industry Group: Biotechnology; Date of First Sale: 2026-05-21; Types of Securities Offered: Debt, Security to be acquired; Business combination transaction: false; Total Offering Amount: 2000000; Total Amount Sold: 250000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals